Inositol phosphate formation in mice prenatally exposed to drugs: Relation to muscarinic receptors and postreceptor effects

被引:17
作者
AbuRoumi, M [1 ]
Newman, ME [1 ]
Yanai, J [1 ]
机构
[1] HADASSAH UNIV HOSP,DEPT PSYCHIAT,BIOL PSYCHIAT LAB,IL-91120 JERUSALEM,ISRAEL
关键词
mice; phenobarbital; heroin; prenatal exposure; septohippocampal cholinergic innervations; diacetylmorphine; sodium fluoride; carbachol; KCI; physostigmine;
D O I
10.1016/0361-9230(95)02131-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mice were exposed to phenobarbital or heroin [diacetylmorphine (DAM)] prenatally by feeding the mother phenobarbital on gestation days 9-18; DAM was injected into the mother on gestation days 9-18. At the age of 50 days, mice exposed to phenobarbital or DAM prenatally were examined for long-term biochemical changes in the postsynaptic septohippocampal system as measured by alterations in formation of the second messenger inositol phosphate (IP). A significant increase in IP formation in response to carbachol was found after prenatal exposure to DAM, An increase in IP formation in response to 20 mM KCl alone or in the additional presence of 10 mM carbachol or 1 mM physostigmine was found after prenatal exposure to phenobarbital or DAM. In addition, a significant increase in IP formation in response to sodium fluoride was found after prenatal exposure to phenobarbital or DAM. It is suggested that an increase in G-protein activation and in the second messenger formation accompanies the early drug-induced upregulation of the muscarinic receptors found in our previous studies.
引用
收藏
页码:183 / 186
页数:4
相关论文
共 31 条
[1]  
ANSON RM, 1992, BRAIN RES, V598, P302
[2]   EVIDENCE FOR THE IMPLICATION OF PHOSPHOINOSITOL SIGNAL TRANSDUCTION IN MU-OPIOID INHIBITION OF DNA-SYNTHESIS [J].
BARG, J ;
BELCHEVA, MM ;
COSCIA, CJ .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (03) :1145-1152
[3]   LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS [J].
BERRIDGE, MJ ;
DOWNES, CP ;
HANLEY, MR .
BIOCHEMICAL JOURNAL, 1982, 206 (03) :587-595
[4]  
BERRIDGE MJ, 1983, J BIOCH, V216, P473
[5]  
CLAMAN AD, 1962, AM J OBSTET GYNECOL, V15, P252
[6]  
COURT JA, 1986, N-S ARCH PHARMACOL, V334, P1016
[7]  
EVA C, 1986, J NEUROCHEM, V446, P1429
[8]  
FORFAR JO, 1973, CLIN PHARMACOL THER, V14, P632
[9]   DIFFERENTIAL COUPLING BETWEEN MUSCARINIC RECEPTORS AND G-PROTEINS IN REGIONS OF THE RAT-BRAIN [J].
GHODSIHOVSEPIAN, S ;
MESSER, WS ;
HOSS, W .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (08) :1385-1391
[10]  
GIL DW, 1985, J PHARMACOL EXP THER, V232, P608